HOME >> BIOLOGY >> NEWS
Obesity has reached epidemic proportions - urgent need for research

Every second German is too fat, every fifth even suffers from pathological obesity (adiposity). Obesity is not only a burden, but also causes physical disorders, some of which may prove fatal. The Deutsche Forschungsgemeinschaft (DFG) invited 40 experts from all over the world to a discussion forum entitled "Genetics, Diet and Disease - Consequences of Obesity" at Leipzig University. Under the chairmanship of Prof. Dr. med. Wieland Kiess, Director of Leipzig University's Children's Clinic, the scientists discussed the causes and effects of obesity and defined the areas where research is urgently needed.

The researchers attending the forum called for the development of guidelines to support doctors and patients in their struggle against "obesity", which has now reached epidemic proportions. Research into adiposity must be intensified and individual projects brought into combination; in particular, we know too little about the side-effects and consequences of obesity. Wide-ranging studies of affected families will have to be undertaken to form an adequate basis for scientists addressing these questions. It is also not clear how hereditary predisposition and a person's way of life influence the genesis of obesity; comprehensive molecular-biological research is required for this.

The chairman, Prof. Dr. Kiess, declared that "Obesity is the prime pathological risk factor today". For the obese, the chances of contracting an illness are several times higher than they are for slim people. Fat people are not only threatened by cardiovascular disorders, but also by diabetes, arteriosclerosis and renal disorders. If a hereditary predisposition is exacerbated by additional dietary deficiencies and lack of exercise, then the pounds will accumulate almost inevitably. "Today, it is almost normal to be obese", stated Prof. Claude Bouchard, co-publisher of the International Handbook on Obesity and Adiposity during the meeting in Leipzig. "Early diagnosis and treatment o
'"/>

Contact: Dr. Heike Velke
heike.velke@dfg.de
49-228-885-2341
Deutsche Forschungsgemeinschaft
18-May-2000


Page: 1 2

Related biology news :

1. Obesity and hypertension: Two epidemics or one?
2. Obesity alone not a good predictor of cardiovascular risk and death, fat distribution proved best
3. Obesity drug inhibits prostate tumor growth
4. Obesity and blood pressure
5. Obesity, kidney genetics, erectile dysfunction among highlighted research at APS Meeting
6. Obesity in Costa Rican children alarming, likely future health burden
7. Obesity prevention program aimed at second graders
8. Obesity not a personal failing, but a battle against biology
9. Obesity sleuths find chronic diseases linked to behavior contrary our DNA
10. Obesity...by choice
11. Obesity may exacerbate a heart disorder in African American females

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Obesity has reached epidemic proportions urgent need for research

(Date:4/1/2015)... 2015   Medisafe ™, the leading global medication ... iOS and Android smartphones and tablets, ... the platform to allow patients to track and correlate ... time, patients will be able to visualize in real-time ... biometrics, such as glucose levels and blood pressure. ...
(Date:3/30/2015)... , Mar. 26, 2015 Research and Markets ... of the "Global Gesture Recognition Market in Automotive ... The analysts forecast the Global Gesture Recognition market in ... over the period 2013-2018. Gesture recognition is ... to different gestures of an individual. Gesture recognition technology ...
(Date:3/24/2015)... , Mar. 24, 2015 Research and Markets ... and Voice Biometrics - Global Strategic Business Report" report to ... Face and Voice Biometrics in US$ Thousands by the following Segments: ... for the US, Canada , Japan ... , Middle East & Africa ...
Breaking Biology News(10 mins):Medisafe Announces Launch of Biometric Integration, Enabling Patients to Stay Adherent to Their Meds and See Tangible Health Results 2Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6
(Date:4/16/2015)... (PRWEB) April 16, 2015 Capillus, ... distribution and physician network in Europe and Asia. ... has appointed Fernando Bermúdez, former Business Development Director ... An industry veteran, Mr. Bermúdez’s professional achievements include ... in Spain, while also penetrating the Portuguese marketplace ...
(Date:4/16/2015)... OncoTAb, Inc., a ... spin-out company, announced today the appointment of physician ... Chief Operating Officer (COO). Cooper brings to OncoTAb ... clinical diagnostic and biotechnology platforms in the fields ... extensive career transcends the field of medical and ...
(Date:4/16/2015)... 2015 /CNW/ - Bioenterprise Corporation is pleased to announce that ... Charlottetown , PEI.  Bioenterprise has established a ... Council for the commercialization of agricultural technologies and innovations. ... PEI ADAPT.  They have been at the heart of ... explains Dave Smardon , President & CEO of ...
(Date:4/16/2015)... -- Avelas Biosciences, an in vivo cancer ... that it has initiated a Phase 1b study of ... primary, non-recurrent breast cancer undergoing surgery. In commencing the ... Steven Chen , M.D., as vice president of ... study will enroll up to 39 women with stage ...
Breaking Biology Technology:Capillus, LLC Extends Laser Hair Therapy Products to Europe and Asia 2OncoTAb Names Dr. David L. Cooper as COO 2Bioenterprise Corporation Expands into the Maritimes 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 2Avelas Biosciences Initiates Phase 1b Trial of AVB-620 in Breast Cancer Patients 3
Cached News: